1 interaction related to mercaptopurine
Febuxostat blocks xanthine oxidase, one of the main routes that inactivate azathioprine's active form, 6-mercaptopurine. In a label study it cut mercaptopurine clearance by 83.2% to 83.8% after a dose of azathioprine, which can lead to severe bone marrow suppression, and the Uloric label contraindicates the combination. An FDA review found 19 cases of serious blood count drops in people taking febuxostat with azathioprine or mercaptopurine, 16 of them hospitalized.